Positive Phase III results for linerixibat in cholestatic pruritus treatment for PBC patients
GSK has announced positive headline results of its ongoing global Phase III clinical trial GLISTEN, which is evaluating the use…
All articles by Eve Thomas
Eve Thomas
Eve Thomas is a reporter writing across a variety of sectors with a specific focus on thematic intelligence. She has a BA in English Literature from the University of Sheffield and an MSt in English from Oxford University.
-
-
Yonalink launches ICTN to position Israel as leader in clinical trial innovation
Clinical trials data platform provider Yonalink has today announced the launch of the Israel Clinical Trials Network (ICTN), a consortium…
-
FDA shares additional draft guidance on CGTs
The US Food and Drug Administration (FDA) has published new draft guidance around the development and application process for new…
-
Barinthus Bio shares ongoing Phase IIb chronic hepatitis B trial results
Barinthus Biotherapeutics has shared its most significant recent data from the ongoing Phase IIb HBV003 clinical trial for chronic hepatitis…
-
Trump 2.0 spells uncertainty for US healthcare, says analyst
An analyst has warned of likely instability in the US' healthcare systems following the election of Donald Trump as the…
-
Corcept’s relacorilant GRADIENT trial misses primary endpoint
Corcept Therapeutics has shared some results from its Phase III GRADIENT trial for relacorilant – its experimental treatment for Cushing’s…
-
Reeves’ 2024 budget promises life sciences investment
Announcing the UK's Budget yesterday (30 October), Rachel Reeves outlined the Labour Party’s investment plans for research and development (R&D)…
-
mRNA licensing agreements surge 800% amid GSK lawsuits
mRNA-based innovator pharmaceuticals have experienced a massive increase in licensing agreement deal values following success with the technology in Covid-19…
-
MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study
A Phase I/II trial (NCT05603312) with MeiraGTx's AAV-GAD Parkinson’s disease gene therapy has met its primary endpoint. The sham-controlled bridging…
-
As mpox spreads, ‘national governments have a moral responsibility to help’
As the number of mpox-related deaths in the Democratic Republic of Congo (DRC) and neighbouring countries continues to climb, international…